Life Sciences
With the service, pharmacists can compare multiple different medications and see how risky the combination is.
Providers can tap into the tool for resources and collaboration.
The co-packaged product, which will be launched in Europe this year, combines Propeller's sensor tech and Novartis' new medication.
The company's drug development CRO, Covance, will integrate Medable's software to expand its decentralized trial capabilities.
The platform will include an AI-enabled patient-engagement tool and smart pricing.
The company is also sponsoring a free video consultation for the first 400 people accessing the service.
A interview with Prof Yasushi Goto, Department of Thoracic Oncology, National Cancer Center Hospital, Japan.